News | Page 2 | bioMérieux Asean countries

CE marking of bioMérieux serology tests for SARS-CoV-2 on VIDAS^®

27 May, 2020

bioMérieux serology tests for SARS-CoV-2 on VIDAS^® undergo validation preceding imminent launch

06 May, 2020

BIOFIRE^® Respiratory Panel 2.1 (RP2.1) with SARS-CoV-2 obtains FDA Emergency Use Authorization

04 May, 2020

First-Quarter 2020 Business Review

24 March, 2020

bioMérieux receives Emergency Use Authorization for BIOFIRE^® COVID-19 test

24 March, 2020

First of 3 diagnostic tests for SARS-CoV-2 coronavirus available from bioMérieux

11 March, 2020

bioMérieux – 2019 Financial Results

02 March, 2020

bioMerieux - Third Quarter 2019 Business Review

23 October, 2019

bioMérieux increases its holding in Hybiome from 54% to 67%

06 June, 2019

Baxter and bioMérieux announce collaboration to improve identification and treatment of acute kidney injury

19 March, 2019

Diagnostics is power